GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » EV-to-FCF

Sartorius Stedim Biotech (Sartorius Stedim Biotech) EV-to-FCF : 84.22 (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sartorius Stedim Biotech's Enterprise Value is $24,992 Mil. Sartorius Stedim Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $297 Mil. Therefore, Sartorius Stedim Biotech's EV-to-FCF for today is 84.22.

The historical rank and industry rank for Sartorius Stedim Biotech's EV-to-FCF or its related term are showing as below:

SDMHF' s EV-to-FCF Range Over the Past 10 Years
Min: 74.78   Med: 124.61   Max: 768.41
Current: 85.63

During the past 13 years, the highest EV-to-FCF of Sartorius Stedim Biotech was 768.41. The lowest was 74.78. And the median was 124.61.

SDMHF's EV-to-FCF is ranked worse than
82.93% of 369 companies
in the Medical Devices & Instruments industry
Industry Median: 26.55 vs SDMHF: 85.63

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-27), Sartorius Stedim Biotech's stock price is $224.44. Sartorius Stedim Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.624. Therefore, Sartorius Stedim Biotech's PE Ratio for today is 61.93.


Sartorius Stedim Biotech EV-to-FCF Historical Data

The historical data trend for Sartorius Stedim Biotech's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech EV-to-FCF Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.93 106.26 118.90 159.46 94.11

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159.46 198.67 138.01 217.92 94.11

Competitive Comparison of Sartorius Stedim Biotech's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's EV-to-FCF falls into.



Sartorius Stedim Biotech EV-to-FCF Calculation

Sartorius Stedim Biotech's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=24992.155/296.745
=84.22

Sartorius Stedim Biotech's current Enterprise Value is $24,992 Mil.
Sartorius Stedim Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $297 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius Stedim Biotech  (OTCPK:SDMHF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sartorius Stedim Biotech's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=224.44/3.624
=61.93

Sartorius Stedim Biotech's share price for today is $224.44.
Sartorius Stedim Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.624.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sartorius Stedim Biotech EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.